Tag: Dr. Kim Samano
Workforce drug positivity increases in more than one-third of U.S. industry sectors examined
One third of U.S. industry sectors experienced year-over-year double-digit increases in workforce drug positivity between 2015 and 2018.
Federal drug testing expanded opiate panel impacting positivity
The dangers associated with opioids misuse are likely elevated based on a testing population that includes drivers, pilots, and other safety-sensitive roles.
Workforce drug positivity at highest rate in a decade
Driven by increases in cocaine, methamphetamine, and marijuana, drug use by the American workforce remains at its highest rate in more than a decade.
Refining our synthetic cannabinoids panel
Our experts continually monitor and adjust our drug tests to offer a standardized panel that detects the most relevant synthetic cannabinoids.
Synthetic drugs: Common questions
Dr. Kim Samano presented information about synthetic cannabinoids ("K2/Spice") and designer stimulants known as “bath salts” in our recent webinar.
